Skip to content

Efficacy and safety of two different doses of magnesium sulphate as adjuvant in spinal anaesthesia

Efficacy of two different doses of magnesium sulphate as adjuvant to 0.5percent hyperbaric bupivacaine in spinal anaesthesia for lower limb surgeries- A Randomized Controlled Trial - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/094076
Enrollment
88
Registered
2025-09-01
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Addition of magnesium sulphate as adjuvant to 0.5 percent hyperbaric bupivacaine in spinal anaesthesia for lower limb surgeries: Group A: will receive 15mg(3ml) of 0.5 percent hyperbari

Sponsors

P Bhavya Malika
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)ASA physical status 1 or 2 2)Undergoing elective lower limb surgery under spinal anaesthesia 3)Height 140 to 180cms 4)Weight 40 to 80kgs

Exclusion criteria

Exclusion criteria: 1)Known allergy to study drugs 2)Contraindications to spinal anaesthesia 3)Significant cardiovascular/renal/hepatic/neuromuscular disorders 4)Psychological disorder

Design outcomes

Primary

MeasureTime frame
Time of requirement of first dose of rescue analgesia(min)Timepoint: upto 12 hrs

Secondary

MeasureTime frame
Time of onset of sensory block(min)Timepoint: ;Time of onset of motor block(min)Timepoint: ;Duration of sensory block(min)Timepoint: ;Duration of motor block(min)Timepoint: ;Hemodynamic changes- HR, SBP, DBP, SpO2 every 5 minutes for first 30 minutes and then every 15 minutes till the end of surgeryTimepoint: ;Post operative VAS score at 1,2,4,6,12 hoursTimepoint: 1,2,4,6,12hours;Incidence of side effects such as post operative nausea and vomiting(PONV), shivering upto 24hoursTimepoint:

Countries

India

Contacts

Public ContactDr Sapna Das

Kalinga Institute of Medical Sciences

amitpdear@gmail.com9437191002

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026